ArticleProceedings of the National Academy of Sciences of the United States of America2020

Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.

Theodore P Braun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.